Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

Cited In for PubMed (Select 12644540)

1.

Machine learning applications in cancer prognosis and prediction.

Kourou K, Exarchos TP, Exarchos KP, Karamouzis MV, Fotiadis DI.

Comput Struct Biotechnol J. 2014 Nov 15;13:8-17. doi: 10.1016/j.csbj.2014.11.005. eCollection 2015. Review.

2.

JNCI and cancer prevention.

Dunn BK, Ghosh S, Kramer BS.

J Natl Cancer Inst. 2015 Feb 24;107(3). pii: djv021. doi: 10.1093/jnci/djv021. Print 2015 Mar.

PMID:
25713150
3.

Development and validation of a personalized, web-based decision aid for lung cancer screening using mixed methods: a study protocol.

Lau YK, Caverly TJ, Cherng ST, Cao P, West M, Arenberg D, Meza R.

JMIR Res Protoc. 2014 Dec 19;3(4):e78. doi: 10.2196/resprot.4039.

4.

Targeting the estrogen pathway for the treatment and prevention of lung cancer.

Burns TF, Stabile LP.

Lung Cancer Manag. 2014 Feb 1;3(1):43-52.

5.

What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK?

O'Dowd EL, McKeever TM, Baldwin DR, Anwar S, Powell HA, Gibson JE, Iyen-Omofoman B, Hubbard RB.

Thorax. 2015 Feb;70(2):161-8. doi: 10.1136/thoraxjnl-2014-205692. Epub 2014 Oct 13.

6.

A review of cancer risk prediction models with genetic variants.

Wang X, Oldani MJ, Zhao X, Huang X, Qian D.

Cancer Inform. 2014 Sep 21;13(Suppl 2):19-28. doi: 10.4137/CIN.S13788. eCollection 2014. Review.

7.

Predicting lung cancer prior to surgical resection in patients with lung nodules.

Deppen SA, Blume JD, Aldrich MC, Fletcher SA, Massion PP, Walker RC, Chen HC, Speroff T, Degesys CA, Pinkerman R, Lambright ES, Nesbitt JC, Putnam JB Jr, Grogan EL.

J Thorac Oncol. 2014 Oct;9(10):1477-84. doi: 10.1097/JTO.0000000000000287.

PMID:
25170644
8.

Evidence based imaging strategies for solitary pulmonary nodule.

Wang YX, Gong JS, Suzuki K, Morcos SK.

J Thorac Dis. 2014 Jul;6(7):872-87. doi: 10.3978/j.issn.2072-1439.2014.07.26.

9.

A risk prediction model for smoking experimentation in Mexican American youth.

Talluri R, Wilkinson AV, Spitz MR, Shete S.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2165-74. doi: 10.1158/1055-9965.EPI-14-0467. Epub 2014 Jul 25.

PMID:
25063521
10.

Comparing benefits from many possible computed tomography lung cancer screening programs: extrapolating from the National Lung Screening Trial using comparative modeling.

McMahon PM, Meza R, Plevritis SK, Black WC, Tammemagi CM, Erdogan A, ten Haaf K, Hazelton W, Holford TR, Jeon J, Clarke L, Kong CY, Choi SE, Munshi VN, Han SS, van Rosmalen J, Pinsky PF, Moolgavkar S, de Koning HJ, Feuer EJ.

PLoS One. 2014 Jun 30;9(6):e99978. doi: 10.1371/journal.pone.0099978. eCollection 2014.

11.

Time to smoke first morning cigarette and lung cancer in a case-control study.

Gu F, Wacholder S, Kovalchik S, Panagiotou OA, Reyes-Guzman C, Freedman ND, De Matteis S, Consonni D, Bertazzi PA, Bergen AW, Landi MT, Caporaso NE.

J Natl Cancer Inst. 2014 Jun 19;106(6):dju118. doi: 10.1093/jnci/dju118. Print 2014 Jun.

PMID:
24948709
12.

Updates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemoprevention.

Kathuria H, Gesthalter Y, Spira A, Brody JS, Steiling K.

Cancers (Basel). 2014 May 16;6(2):1157-79. doi: 10.3390/cancers6021157.

13.

Heavy smoking and lung cancer: are women at higher risk? Result of the ICARE study.

Papadopoulos A, Guida F, Leffondré K, Cénée S, Cyr D, Schmaus A, Radoï L, Paget-Bailly S, Carton M, Menvielle G, Woronoff AS, Tretarre B, Luce D, Stücker I.

Br J Cancer. 2014 Mar 4;110(5):1385-91. doi: 10.1038/bjc.2013.821. Epub 2014 Jan 14.

14.

Fifty years of tobacco carcinogenesis research: from mechanisms to early detection and prevention of lung cancer.

Hecht SS, Szabo E.

Cancer Prev Res (Phila). 2014 Jan;7(1):1-8. doi: 10.1158/1940-6207.CAPR-13-0371.

15.

Development of a genotyping microarray for studying the role of gene-environment interactions in risk for lung cancer.

Baldwin DA, Sarnowski CP, Reddy SA, Blair IA, Clapper M, Lazarus P, Li M, Muscat JE, Penning TM, Vachani A, Whitehead AS.

J Biomol Tech. 2013 Dec;24(4):198-217. doi: 10.7171/jbt.13-2404-004.

16.

Lung cancer screening with low-dose computed tomography.

Chiles C.

Radiol Clin North Am. 2014 Jan;52(1):27-46. doi: 10.1016/j.rcl.2013.08.006.

17.

Circulating inflammation markers and prospective risk for lung cancer.

Shiels MS, Pfeiffer RM, Hildesheim A, Engels EA, Kemp TJ, Park JH, Katki HA, Koshiol J, Shelton G, Caporaso NE, Pinto LA, Chaturvedi AK.

J Natl Cancer Inst. 2013 Dec 18;105(24):1871-80. doi: 10.1093/jnci/djt309. Epub 2013 Nov 18.

18.

Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial era.

Brothers JF, Hijazi K, Mascaux C, El-Zein RA, Spitz MR, Spira A.

BMC Med. 2013 Jul 19;11:168. doi: 10.1186/1741-7015-11-168. Review.

19.

Targeting of low-dose CT screening according to the risk of lung-cancer death.

Kovalchik SA, Tammemagi M, Berg CD, Caporaso NE, Riley TL, Korch M, Silvestri GA, Chaturvedi AK, Katki HA.

N Engl J Med. 2013 Jul 18;369(3):245-54. doi: 10.1056/NEJMoa1301851.

20.

Using current smoking prevalence to project lung cancer morbidity and mortality in Georgia by 2020.

Davis VN, Lavender A, Bayakly R, Ray K, Moon T.

Prev Chronic Dis. 2013 May 9;10:E74. doi: 10.5888/pcd10.120271.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk